home / stock / inzy / inzy news

INZY News and Press, Inozyme Pharma Inc. From 04/29/24

Stock Information
Company Name: Inozyme Pharma Inc.
Stock Symbol: INZY
Market: NASDAQ
Website: inozyme.com
Menu
INZY INZY Quote INZY Short INZY News INZY Articles INZY Message Board
Get INZY Alerts

News, Short Squeeze, Breakout and More Instantly...
INZY - RMBS, SANM and WGS are among after hour movers

2024-04-29 17:00:21 ET Gainers: GeneDx Holdings  ( WGS ) +22% . Zapp Electric Vehicles Group  ( ZAPP ) +8% . Amkor Technology ( AMKR ) +7% . Woodward ( WWD ) +6% . NXP Semiconductors ( NXPI ) +5% . Losers: F5 ( ...
INZY - INZY Price Target Alert: $14.00. Issued by H.C. Wainwright

2024-04-09 08:00:07 ET Edward White from H.C. Wainwright issued a price target of $14.00 for INZY on 2024-04-09 06:36:00. The adjusted price target was set to $14.00. At the time of the announcement, INZY was trading at $5.87. INZY currently trades -24.97% versus its 52 ...

INZY - Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency

- Favorable safety and immunogenicity profile in ABCC6 Deficiency, with clinical improvements in vascular pathology, visual function and patient reported outcomes (PROs) - - Natural history study highlights stroke as common feature among patients with early-onset ABCC6 Deficiency - ...

INZY - Trend Tracker for (INZY)

2024-04-07 01:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
INZY - Catalyst Watch: CPI reveal, big bank earnings & AI talk from Intel and Marvell

2024-04-05 15:00:12 ET More on the markets SPY: The Correction May Be Massive S&P 500: International Risk Assessment My Current View Of The Market: April 2024 Edition (Technical Analysis) S&P 500 holds its bullish trend as it defends the 20-day MA yet...

INZY - Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference

BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferati...

INZY - ANGI, MLKN and KOD are among after hour movers

2024-03-27 16:50:31 ET Gainers: Athira Pharma  ( ATHA ) +5% . ContextLogic  ( WISH ) +5% . Angi  ( ANGI ) +4% . Xeris Biopharma Holdings ( XERS ) +4% . Inozyme Pharma ( INZY ) +3% . Losers: MillerKnoll ( ...
INZY - Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024

- Company to host conference call and webcast featuring key opinion leaders on Monday, April 8, 2024 at 8:00 a.m. ET - BOSTON, March 26, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare dis...

INZY - How to Take Advantage of moves in (INZY)

2024-03-18 02:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

INZY - Inozyme Pharma GAAP EPS of -$1.37

2024-03-12 09:46:49 ET More on Inozyme Pharma Inozyme: Several Catalysts To Move Rare Disease Pipeline Programs Forward Seeking Alpha’s Quant Rating on Inozyme Pharma Historical earnings data for Inozyme Pharma Financial information for Inozyme Pharma ...
Previous 10 Next 10